<?xml version="1.0" encoding="UTF-8" standalone="yes"?><?xml-stylesheet type="text/xsl" href="/oai-pmh-repository/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
    <responseDate>2026-10-14T06:15:32Z</responseDate>
    <request verb="GetRecord" identifier="oai:data.mendeley.com/v9c4tgxy8x.1" metadataPrefix="oai_dc">https://data.mendeley.com/oai</request>
    <GetRecord>
        <record>
            <header>
                <identifier>oai:data.mendeley.com/v9c4tgxy8x.1</identifier>
                <datestamp>2025-05-23T21:42:02Z</datestamp>
            </header>
            <metadata><oai_dc:dc xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <dc:creator>Gong, Jinshuo</dc:creator>
    <dc:title>Oral vaccination with recombinant Lactobacillus casei expressing Malt of Aeromonas veronii and IFN-γ as molecular adjuvant</dc:title>
    <dc:publisher>Mendeley Data</dc:publisher>
    <dc:description>Aeromonas veronii is a pathogen of human-livestock-aquatic organisms that causes notable economic loss in the aquaculture industry and threatens public health security. Antibiotics are the first-line treatment against this pathogen. However, prolonged use of antibiotics can lead to bacterial resistance and disrupt ecological balance. Oral recombinant Lactobacillus casei vaccine is a potential alternative to antibiotic resistance in diverse pathogenic bacteria. In recent years, adjuvants have been found to be effective in enhancing the immunogenicity of recombinant subunit vaccines. IFN-γ, as a molecular adjuvant, enhances the host immune response to pathogens, reduces inflammatory responses, and enhances long-term protection by vaccines through multiple pathways. Therefore, crucian carp-derived IFN-γ showing high homologous adaptation with fish was used as a molecular adjuvant for subunit vaccines. On this basis, the highly immunogenic Malt gene from A. veronii was combined with IFN-γ to construct recombinant L. casei (Lc-pPG-Malt-IFN-γ, Lc-pPG-Malt, and Lc-pPG-IFN-γ). The immunological effects of the three recombinants were evaluated. Lc-pPG-Malt and Lc-pPG-Malt-IFN-γ showed higher stimulation of IgM antibodies. Among the three, Lc-pPG-Malt-IFN-γ showed the highest and significant upregulation of the activities of humoral immune response-related enzymes, expression of cellular immune response-related gene, phagocytic activity, and phagocytic index. All recombinants colonised well in the gut of crucian carp, with Lc-pPG-Malt-IFN-γ having the highest colonisation rate. Moreover, the Lc-pPG-Malt-IFN-γ group (64%) had a better survival rate than that of Lc-pPG-Malt (47%), Lc-pPG-IFN-γ, Lc-pPG (control), and phosphate-buffered saline (PBS; blank) groups with the virulent strain A. veronii challenge. In conclusion, subunit vaccines of recombinant L. casei with an antigenic conjugate molecular adjuvant (IFN-γ) were more effective in immunising crucian carp compared with recombinant L. casei vaccines with a single antigen stimulation.</dc:description>
    <dc:subject>Aquaculture</dc:subject>
    <dc:subject>Oral Vaccine</dc:subject>
    <dc:type>Dataset</dc:type>
    <dc:identifier>doi:10.17632/v9c4tgxy8x.1</dc:identifier>
    <dc:identifier>oai:data.mendeley.com/v9c4tgxy8x.1</dc:identifier>
    <dc:rights>Creative Commons Attribution 4.0 International</dc:rights>
    <dc:rights>http://creativecommons.org/licenses/by/4.0</dc:rights>
    <dc:relation>https://data.mendeley.com/datasets/v9c4tgxy8x</dc:relation>
    <dc:date>2025-05-23T21:42:02Z</dc:date>
</oai_dc:dc></metadata>
        </record>
    </GetRecord>
</OAI-PMH>
